Andrea Leonards
Foot & Ankle Surgery · Morgan City, LANPI 1740448125
Payments from drug & device makers
What this record shows
Stryker accounts for 77.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $899 and has fallen 98.0% since, to $18 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in LA, where the typical reported total is $2,260.
Across 38 payments — averaging $43.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Smith+Nephew$178
- Musculoskeletal Transplant Foundation Inc.$33
- Arthrosurface Incorporated$28
- Kerecis Limited$27
- Amgen$26
- plus $80 from 5 others
What the payments were for
- Travel & lodging$72544%
- Food & beverage$92156%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 14 | $1,274 |
| Smith+Nephew | 10 | $178 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $33 |
| Arthrosurface Incorporated | 2 | $28 |
| Kerecis Limited | 2 | $27 |
| Amgen | 2 | $26 |
| Zyla Life Sciences, Inc. | 1 | $19 |
| LEO Pharma Inc. | 1 | $18 |
| Trice Medical, Inc. | 1 | $16 |
| KCI USA, Inc. | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HOFFMANN$725
- ANCHORAGE$151
- AUGMENT INJECTABLE$150
How this compares
$1,646 in reported general payments places this provider in the 45th percentile of 92 foot & ankle surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluconazole | 72 | $1,371 |
| Colchicine | 17 | $755 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 32 | $683 |
| Gabapentin | 71 | $547 |
| Mupirocin | 46 | $481 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $370 |
| Naproxen | 42 | $333 |
| Pregabalin | 13 | $222 |
| Allopurinol | 17 | $191 |
| Ibuprofen | 13 | $166 |
| Prednisone | 56 | $110 |
| Tramadol Hcl | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Morgan City
- Brian BensonLeesville$278K
- Meredith WarnerBaton Rouge$232K
- Tyson GreenLake Charles$203K
- Bryon McKennaThibodaux$131K
- Mohamad IssaNew Orleans$24K
- Leon WatkinsMetairie$18K
- Phuoc BuiMinden$15K
- Henrique HilarioShreveport$14K
- Beau WillisMetairie$13K
- Nimish ChokshiMetairie$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.